Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2026-02-27 @ 4:31 PM
Study NCT ID:
NCT02245412
Status:
TERMINATED
Last Update Posted:
2019-01-03
First Post:
2014-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization: